EBS
Emergent BioSolutions Inc.
+0.18 (+2.67%)6.93USD512K成交股數355M市值–本益比(近四季)0.5股價營收比+66.3%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 234M+5% | 156M-20% | 231M-21% | 141M-45% | 222M-26% | 195M-28% | 294M-13% | 255M+55% | 300M | 271M | 338M | 164M |
| 營業成本 | 97.1M | 72.0M | 85.9M | 66.9M | 88.5M | 118M | 123M | 296M | 145M | 177M | 191M | 153M |
| 毛利 | 137M+3% | 84.1M-17% | 145M-10% | 74.0M-254% | 134M-10% | 101M+16% | 161M+15% | −48.0M-1080% | 148M | 87.2M | 141M | 4.9M |
| 毛利率 | 58.6% | 53.9% | 62.8% | 52.5% | 60.2% | 52.0% | 54.9% | -18.8% | 49.2% | 32.2% | 41.6% | 3.0% |
| 研發費用 | 9.2M | 10.5M | 13.5M | 12.5M | 15.1M | 9.1M | 13.8M | 32.7M | 15.1M | 15.3M | 26.0M | 40.7M |
| 銷售管理費用 | 44.6M | 46.6M | 38.9M | 43.7M | 52.4M | 60.8M | 76.6M | 85.9M | 84.7M | 86.0M | 91.4M | 101M |
| 營業利益 | −125M-351% | 10.5M-211% | 76.5M+19% | 1.6M-101% | 49.9M+25% | −9.5M-96% | 64.5M-122% | −204M+38% | 39.8M | −242M | −293M | −148M |
| 營業利益率 | -53.4% | 6.7% | 33.1% | 1.1% | 22.5% | -4.9% | 22.0% | -79.9% | 13.2% | -89.5% | -86.7% | -89.8% |
| 稅後淨利 | −180M-365% | 6.8M-122% | 51.2M-55% | −12.0M-96% | 68.0M+656% | −31.3M-88% | 115M-144% | −283M+52% | 9.0M | −263M | −261M | −186M |
| 淨利率 | -76.9% | 4.4% | 22.2% | -8.5% | 30.6% | -16.1% | 39.1% | -111.2% | 3.0% | -97.4% | -77.4% | -113.3% |
| 稀釋 EPS | -3.49-393% | 0.07-116% | 0.91-56% | -0.22-96% | 1.19+600% | -0.45-91% | 2.06-140% | -5.38+45% | 0.17 | -5.08 | -5.16 | -3.71 |
| 稀釋股數 | 51.6M | 56.5M | 56.5M | 54.2M | 57.3M | 53.0M | 55.6M | 52.6M | 52.2M | 51.8M | 50.7M | 50.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 140M | 160M | 246M | 267M | 149M | 99.5M | 150M | 69.7M | 78.5M | 87.8M | 88.6M | 430M |
| 應收帳款 | 190M | 122M | 150M | 79.8M | 204M | 155M | 121M | 196M | 234M | 217M | 290M | 156M |
| 存貨 | 304M | 328M | 356M | 339M | 314M | 312M | 323M | 318M | 333M | 354M | 354M | 368M |
| 總資產 | 1.1B | 1.3B | 1.5B | 1.4B | 1.4B | 1.4B | 1.5B | 1.5B | 1.8B | 1.9B | 2.2B | 2.9B |
| 有息負債 | 582M | 574M | 663M | 668M | 666M | 664M | 662M | 447M | 447M | 448M | 448M | 448M |
| 總負債 | 775M | 797M | 879M | 881M | 873M | 907M | 969M | 1.1B | 1.1B | 1.2B | 1.2B | 1.7B |
| 股東權益 | 341M | 523M | 583M | 536M | 553M | 483M | 508M | 386M | 664M | 697M | 958M | 1.2B |
| 負債比 | 69.4% | 60.4% | 60.1% | 62.2% | 61.2% | 65.3% | 65.6% | 74.5% | 63.2% | 63.2% | 56.1% | 59.2% |
| 淨現金(現金 − 有息負債) | −442M | −413M | −418M | −401M | −517M | −564M | −512M | −377M | −368M | −360M | −359M | −17.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −33.8M | – | – | −11.2M-82% | – | – | – | −62.6M | – | – | −184M |
| 資本支出 | – | 2.4M | – | – | 3.6M | – | – | – | 10.8M | – | – | 15.1M |
| 自由現金流 | – | −36.2M | – | – | −14.8M-80% | – | – | – | −73.4M | – | – | −199M |
| 折舊攤銷 | – | 23.5M | – | – | 25.4M | – | – | – | 27.9M | – | – | 34.6M |
| 買回庫藏股 | – | 9.0M | – | – | 0.00 | – | – | – | – | – | – | 0.00 |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -23.2% | – | – | -6.7% | – | – | – | -24.4% | – | – | -121.2% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 683M
| MCM Products | 457M | 66.9% | -10.4% |
|---|---|---|---|
| Commercial Products | 226M | 33.1% | -43.3% |
產品／服務2025 年度 · 1.5B
| Product And Service | 705M | 47.5% | -30.4% |
|---|---|---|---|
| Medical Countermeasures MCM Product | 457M | 30.7% | -10.4% |
| Commercial Product | 226M | 15.2% | -43.3% |
| All Other Revenue | 60.1M | 4.0% | -55.4% |
| Contracts And Grants | 37.7M | 2.5% | +25.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 743M | -28.8% | 52.6M | 7.1% | 0.93 | 157M |
| FY2024 | 1.0B | -0.5% | −191M | -18.3% | -3.60 | 35.8M |
| FY2023 | 1.0B | -6.1% | −761M | -72.5% | -14.85 | −258M |
| FY2022 | 1.1B | -37.0% | −212M | -18.9% | -4.22 | −150M |
| FY2021 | 1.8B | +14.0% | 220M | 12.4% | 4.06 | 96.1M |
| FY2020 | 1.6B | +40.6% | 306M | 19.7% | 5.68 | 395M |
| FY2019 | 1.1B | +41.4% | 54.5M | 4.9% | 1.04 | 101M |
| FY2018 | 782M | – | 62.7M | 8.0% | 1.22 | −30.3M |